GJA1 | Gap junction protein, alpha 1, 43kDa | Cancer-related genes Disease related genes Predicted membrane proteins
| | | | | Mixed |
GJB1 | Gap junction protein, beta 1, 32kDa | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
GJB6 | Gap junction protein, beta 6, 30kDa | Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
GLRA2 | Glycine receptor, alpha 2 | FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
GPM6A | Glycoprotein M6A | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |
GPR108 | G protein-coupled receptor 108 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
GPR123 | G protein-coupled receptor 123 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
GPR160 | G protein-coupled receptor 160 | G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| | | | | Mixed |
GPRC5B | G protein-coupled receptor, class C, group 5, member B | G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
GRIN2A | Glutamate receptor, ionotropic, N-methyl D-aspartate 2A | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins RAS pathway related proteins
| | | | | Tissue enriched |
HHATL | Hedgehog acyltransferase-like | Predicted membrane proteins
| | | | | Group enriched |
HTR3E | 5-hydroxytryptamine (serotonin) receptor 3E, ionotropic | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
JKAMP | JNK1/MAPK8-associated membrane protein | Cancer-related genes Predicted membrane proteins
| | | | | Expressed in all |
KCNK1 | Potassium channel, subfamily K, member 1 | Predicted membrane proteins Voltage-gated ion channels
| | | | | Mixed |
KCNQ1 | Potassium voltage-gated channel, KQT-like subfamily, member 1 | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
KIDINS220 | Kinase D-interacting substrate, 220kDa | Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
KISS1R | KISS1 receptor | Disease related genes G-protein coupled receptors Potential drug targets Predicted membrane proteins Transporters
| | | | | Not detected |
LAPTM4A | Lysosomal protein transmembrane 4 alpha | Predicted membrane proteins
| | | | | Expressed in all |
LCLAT1 | Lysocardiolipin acyltransferase 1 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
MARCH5 | Membrane-associated ring finger (C3HC4) 5 | Mitochondrial proteins Predicted membrane proteins
| | | | | Expressed in all |
MFN1 | Mitofusin 1 | Mitochondrial proteins Plasma proteins Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
MFSD11 | Major facilitator superfamily domain containing 11 | Predicted membrane proteins
| | | | | Expressed in all |
MGST1 | Microsomal glutathione S-transferase 1 | Enzymes Mitochondrial proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
MPDU1 | Mannose-P-dolichol utilization defect 1 | Disease related genes Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
MPV17L | MPV17 mitochondrial membrane protein-like | Predicted intracellular proteins Predicted membrane proteins
| | | | | Mixed |
MS4A12 | Membrane-spanning 4-domains, subfamily A, member 12 | Predicted membrane proteins
| | | | | Group enriched |
MS4A2 | Membrane-spanning 4-domains, subfamily A, member 2 | FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Mixed |
MS4A3 | Membrane-spanning 4-domains, subfamily A, member 3 (hematopoietic cell-specific) | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
MS4A8 | Membrane-spanning 4-domains, subfamily A, member 8 | Predicted membrane proteins
| | | | | Group enriched |
OCLN | Occludin | Disease related genes Potential drug targets Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enhanced |
OXA1L | Oxidase (cytochrome c) assembly 1-like | Mitochondrial proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
PANX1 | Pannexin 1 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
PLLP | Plasmolipin | Predicted membrane proteins
| | | | | Mixed |
PLP1 | Proteolipid protein 1 | Cancer-related genes Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
PPAPDC3 | Phosphatidic acid phosphatase type 2 domain containing 3 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
PRRT4 | Proline-rich transmembrane protein 4 | Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
PTPLAD1 | Protein tyrosine phosphatase-like A domain containing 1 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
RNF121 | Ring finger protein 121 | Predicted membrane proteins
| | | | | Expressed in all |
RNFT2 | Ring finger protein, transmembrane 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
SCAMP2 | Secretory carrier membrane protein 2 | Predicted membrane proteins
| | | | | Expressed in all |
SCAMP3 | Secretory carrier membrane protein 3 | Predicted membrane proteins
| | | | | Expressed in all |
SCAMP4 | Secretory carrier membrane protein 4 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
SFXN3 | Sideroflexin 3 | Mitochondrial proteins Predicted membrane proteins
| | | | | Expressed in all |
SLC11A2 | Solute carrier family 11 (proton-coupled divalent metal ion transporter), member 2 | Disease related genes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC12A8 | Solute carrier family 12, member 8 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC13A3 | Solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 3 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC14A1 | Solute carrier family 14 (urea transporter), member 1 (Kidd blood group) | Blood group antigen proteins Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC15A3 | Solute carrier family 15 (oligopeptide transporter), member 3 | Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Expressed in all |
SLC15A4 | Solute carrier family 15 (oligopeptide transporter), member 4 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC16A3 | Solute carrier family 16 (monocarboxylate transporter), member 3 | Predicted membrane proteins Transporters
| | | | | Expressed in all |